Fiduciary Alliance LLC Has $4.58 Million Stock Holdings in Colgate-Palmolive (NYSE:CL)

Fiduciary Alliance LLC lifted its holdings in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 9.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 48,910 shares of the company's stock after buying an additional 4,181 shares during the quarter. Fiduciary Alliance LLC's holdings in Colgate-Palmolive were worth $4,583,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of CL. Brighton Jones LLC grew its holdings in shares of Colgate-Palmolive by 4.4% in the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company's stock valued at $962,000 after buying an additional 450 shares during the period. Waldron Private Wealth LLC raised its position in Colgate-Palmolive by 31.7% in the 4th quarter. Waldron Private Wealth LLC now owns 7,418 shares of the company's stock valued at $674,000 after buying an additional 1,786 shares during the last quarter. Chicago Partners Investment Group LLC lifted its stake in Colgate-Palmolive by 16.2% in the 4th quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company's stock valued at $591,000 after acquiring an additional 943 shares in the last quarter. Independence Bank of Kentucky boosted its holdings in Colgate-Palmolive by 71.5% during the fourth quarter. Independence Bank of Kentucky now owns 7,793 shares of the company's stock worth $708,000 after purchasing an additional 3,250 shares during the last quarter. Finally, DAVENPORT & Co LLC grew its position in Colgate-Palmolive by 0.8% in the fourth quarter. DAVENPORT & Co LLC now owns 43,136 shares of the company's stock valued at $3,921,000 after purchasing an additional 361 shares in the last quarter. 80.41% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the company. Piper Sandler reduced their price target on Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating for the company in a research report on Monday, March 31st. Wall Street Zen downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th. JPMorgan Chase & Co. raised their price objective on Colgate-Palmolive from $95.00 to $103.00 and gave the company an "overweight" rating in a research report on Monday, April 28th. Barclays dropped their price target on Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating on the stock in a research note on Friday, April 11th. Finally, Wells Fargo & Company lifted their price objective on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the stock an "underweight" rating in a research report on Wednesday, April 2nd. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and ten have issued a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $102.12.

Colgate-Palmolive Price Performance

CL stock traded down $0.15 during midday trading on Thursday, reaching $90.05. The company had a trading volume of 1,416,195 shares, compared to its average volume of 4,687,391. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30. The stock has a 50 day moving average price of $91.92 and a 200-day moving average price of $91.25. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. The company has a market capitalization of $72.98 billion, a price-to-earnings ratio of 25.58, a price-to-earnings-growth ratio of 4.20 and a beta of 0.39.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings data on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.86 by $0.05. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. The business had revenue of $4.91 billion for the quarter, compared to analysts' expectations of $4.92 billion. During the same period last year, the firm posted $0.86 earnings per share. The firm's quarterly revenue was down 3.0% compared to the same quarter last year. Equities research analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, May 15th. Shareholders of record on Thursday, April 17th were paid a dividend of $0.52 per share. This is an increase from Colgate-Palmolive's previous quarterly dividend of $0.50. The ex-dividend date was Thursday, April 17th. This represents a $2.08 annualized dividend and a yield of 2.31%. Colgate-Palmolive's payout ratio is presently 58.76%.

Colgate-Palmolive announced that its Board of Directors has authorized a share repurchase plan on Thursday, March 20th that authorizes the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization authorizes the company to buy up to 6.8% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's board of directors believes its stock is undervalued.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.